Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Mouse model developed for the study of alpha-gal meat allergy

March 14, 2017

TiGenix initiates phase Ib/IIa trial of Cx-611 to treat sepsis in community-acquired pneumonia

Jan. 31, 2017

Eagle Pharmaceuticals completes NDA submission for Ryanodex

Jan. 24, 2017

AnaMar reports 5-HT2B receptor antagonists

Jan. 17, 2017

AdAlta reports additional preclinical data for AD-114 in lung and liver fibrosis

Jan. 11, 2017

Mutations in FAM105B gene may be involved in autoinflammatory diseases

Nov. 29, 2016

Actelion Pharmaceuticals describes TPHI1 inhibitors

Nov. 22, 2016

Eagle Pharmaceuticals initiates rolling NDA for Ryanodex in EHS

Nov. 14, 2016

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

NIH grants support work at Feinstein Institute on bioelectronic medicine and sepsis

Aug. 19, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.